Literature DB >> 11950168

Species differences in the distribution of drug-metabolizing enzymes in the pancreas.

Alexis B Ulrich1, Jens Standop, Bruno M Schmied, Matthias B Schneider, Terence A Lawson, Parviz M Pour.   

Abstract

We investigated the cellular expression of 9 cytochrome P450-isozymes (CYP1A1, CYPIA2, CYP2B6, CYP2C8,9,19, CYP2D1, CYP2E1, CYP3A1, CYP3A2, CYP3A4) and 3 glutathione S-transferase-isozymes (GST-pi, GST-alpha. GST-mu) in the pancreas of hamsters, mice, rats, rabbits, pigs, dogs and monkeys, and in comparison with the human pancreas. A wide variation was found in the cellular localization of these enzymes between the 8 species. Most enzymes were expressed in the pancreas of the hamster, mouse, monkey and human, whereas rats, pigs, rabbits and dogs were lacking several isozymes. However, in all of the species the islet cells expressed more enzymes than ductal and acinar cells. An exclusive expression of enzymes in the islet cells was found in the hamster (CYP2E1). mouse (CYP1A1 , CYP1A2, GST-alpha, GST-mu), rat (CYP2C8,9, 19). rabbit (CYP1A2, CYP2B6, GST-pi), and pig (CYP1AI). Although no polymorphism was found in the pancreas of animals, in human tissue four enzymes were missing in about 50% of the cases. The results imply a greater importance of the islet cells in the metabolism of xenobiotics within the pancreas. The differences in the distribution of these drug-metabolizing enzymes in the pancreas between the species call for caution when extrapolating experimental results to humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950168     DOI: 10.1080/019262302753559588

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  10 in total

Review 1.  Reappraisal of xenobiotic-induced, oxidative stress-mediated cellular injury in chronic pancreatitis: a systematic review.

Authors:  Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Porous scaffolds support extrahepatic human islet transplantation, engraftment, and function in mice.

Authors:  Romie F Gibly; Xiaomin Zhang; William L Lowe; Lonnie D Shea
Journal:  Cell Transplant       Date:  2013       Impact factor: 4.064

3.  Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds.

Authors:  K A Hlavaty; R F Gibly; X Zhang; C B Rives; J G Graham; W L Lowe; X Luo; L D Shea
Journal:  Am J Transplant       Date:  2014-06-06       Impact factor: 8.086

4.  Disrupted pancreatic exocrine differentiation and malabsorption in response to chronic elevated systemic glucocorticoid.

Authors:  Karen Wallace; Paul A Flecknell; Alastair D Burt; Matthew C Wright
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

5.  Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.

Authors:  Donghui Li; Li Jiao; Yanan Li; Mark A Doll; David W Hein; Melissa L Bondy; Douglas B Evans; Robert A Wolff; Renato Lenzi; Peter W Pisters; James L Abbruzzese; Manal M Hassan
Journal:  Carcinogenesis       Date:  2005-06-29       Impact factor: 4.944

Review 6.  Pancreas and Adverse Drug Reactions: A Literature Review.

Authors:  Konrad Sosnowski; Piotr Nehring; Adam Przybyłkowski
Journal:  Drug Saf       Date:  2022-07-05       Impact factor: 5.228

Review 7.  Overview of exocrine pancreatic pathobiology.

Authors:  Arun R Pandiri
Journal:  Toxicol Pathol       Date:  2013-11-03       Impact factor: 1.902

8.  Selective expression of CYP2A13 in human pancreatic α-islet cells.

Authors:  Yu Guo; Liang-Ru Zhu; Gang Lu; Hui Wang; Jun-Yan Hong
Journal:  Drug Metab Dispos       Date:  2012-07-13       Impact factor: 3.922

9.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

Review 10.  What is the origin of pancreatic adenocarcinoma?

Authors:  Parviz M Pour; Krishan K Pandey; Surinder K Batra
Journal:  Mol Cancer       Date:  2003-01-22       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.